Joanne Lester PhD, CRNP, ANP-BC, AOCN

Joanne Lester PhD, CRNP, ANP-BC, AOCN
Nurse PractitionerCollege of Nursingjoanne.lester@osumc.edu
James Cancer Hospital 300 W 10th Avenue Columbus OH 43210
Phone:614-293-0010Fax: 614-366-2732
  • Non-Member

General Research Interest

Cancer survivorship across the continuum, specifically issues experienced by breast cancer survivors.  In addition, women at increased risk of breast cancer development, tissue markers relevant to risk status, and adherence to chemoprevention.

Research Description

Dr. Lester is currently exploring professional barriers related to personalized cancer survivorship care in Ohio, specifically in counties with minimal or no access to cancer care, including Appalachia.  The development of a mentored professional nursing education model may enhance survivorship care across the continuum.  These research efforts are funded by Susan G. Komen For the Cure, Columbus Afffiliate. Dr. Lester has developed the Urogenital Atrophy Questionnire, a self-report instrument that characterizes symptoms related to urogenital atrophy. A pilot study is in progress to identify reliable objective markers of atrophic vaginitis in breast cancer survivors. Combined, these measures will provide a brief and concise instrument for use in the oncology clinical setting that measures the signs and symptoms of urogenital atrophy. Pending is a pilot study to measure the anti-inflammatory effects of omega 3 fatty acids on atrophic vaginitis in breast cancer survivors. These research efforts are funded by the Oncology Nursing Society and the Rehabilitation Nurses' Foundation.

Transinstitutional Work

Dr. Lester is working in collaboration with Lisa Yee, MD and her studies related to breast tissue biomarkers in women at increased risk of breast cancer development.  Adherence to chemoprevention and patient interest in healthy lifestyle behaviors in this population are also of interest.

Current Publications

  • Goode ELRisk of Ovarian Cancer and the NF-?B Pathway: Genetic Association with IL1A and TNFSF10.Cancer Res 74 852-61 2/1/2014
  • Lester JSafe handling and administration considerations of oral anticancer agents in the clinical and home setting.Clin J Oncol Nurs 16(6) E192-7 12/1/2012
  • Lester JRestoring and maintaining urinary function.Semin Oncol Nurs 28(3) 163-9 8/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu